Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Illumina, Inc.    ILMN

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/17/2017 02/21/2017 02/22/2017 02/23/2017 02/24/2017 Date
163.37(c) 162.15(c) 162.3(c) 161.01(c) 160(c) Last
892 449 710 410 639 674 562 598 750 824 Volume
+1.28% -0.75% +0.09% -0.79% -0.63% Change
More quotes
Financials ($)
Sales 2017 2 646 M
EBIT 2017 709 M
Net income 2017 480 M
Finance 2017 841 M
Yield 2017 -
Sales 2018 2 997 M
EBIT 2018 850 M
Net income 2018 580 M
Finance 2018 1 289 M
Yield 2018 -
P/E ratio 2017 49,38
P/E ratio 2018 40,80
EV / Sales2017 8,53x
EV / Sales2018 7,38x
Capitalization 23 408 M
More Financials
Company
Illumina, Inc. develops, manufactures and markets integrated systems for the analysis of genetic variation and function.The company provides sequencing and array-based solutions for genetic analysis in addition to selling products, it provide genotyping, NIPT and whole-genome sequencing... 
More about the company
Surperformance© ratings of Illumina, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on ILLUMINA, INC.
02/24 ILLUMINA : Sources Sought Notice - 66-- Infinium Multi-Ethnic Global Kit
02/24 ILLUMINA : Patent Issued for Array Domains Having Rotated Patterns (USPTO 956656..
02/22 INSIDER TRADING ACTIVITY ILLUMINA, I : ILMN) – Director Sold 600 shares of..
02/21 ILLUMINA, INC. (NASDAQ : ILMN) Files An 8-K Departure of Directors or Certain Of..
02/21 ILLUMINA INC : Change in Directors or Principal Officers (form 8-K)
02/21 ILLUMINA : to Webcast Live Presentation at the Cowen and Company Annual Health C..
02/20 ILLUMINA : Names John W. Thompson to Its Board of Directors, Bringing More Than ..
02/17 ILLUMINA : Presolicitation Notice - Illumina MiSeq Annual Service Agreement
02/14 ILLUMINA : Management's Discussion and Analysis of Financial Condition and Resul..
02/14 ILLUMINA, INC. : Lundin Law PC Announces Securities Class Action Lawsuit against..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
02/09 Infineon, Cree warn U.S. might block Wolfspeed deal
02/02 EU probes online sales in electronics, video games, hotels
01/31DJTHERMO FISHER SCIENTIFIC : Earnings, Sales Rise
01/31DJDANAHER : Revenue, Profit Rise
01/30DJEUROPEAN MORNING BRIEFING : Corporate Events
More sector news : Advanced Medical Equipment & Technology - NEC
4-Traders Strategies on ILLUMINA, INC. 
2015We anticipate a reversal
2013End of the technical recovery
More Strategies
Latest Tweets
02/24Illumina, Inc. $ILMN Stock Rating Upgraded by Vetr Inc.  
02/24Illumina CEO Francis deSouza describes his life, path to leading and vision ..
8
02/24Drive value for your genomics . Apply to Illumina Accelerator before Mar. 1 ..
5
02/23Illumina, Inc. $ILMN Upgraded to Strong-Buy at Vetr Inc.  
02/23Illumina upgraded by Vetr Inc. to strong-buy. $181.98 PT.  
More tweets
Qtime:85
News from SeekingAlpha
02/23 Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q4 2016 Update
02/21 This Biotech ETF Looks Primed To Rally Again
02/16 SOCIAL MEDIA INSIGHTS : All Talk And No Action
02/13 Illumina readies NovaSeq S1 and S4 for shipment in Q3
02/09 VALUATION DASHBOARD : Healthcare - Update
Advertisement
Chart ILLUMINA, INC.
Duration : Period :
Illumina, Inc. Technical Analysis Chart | ILMN | US4523271090 | 4-Traders
Full-screen chart
Technical analysis trends ILLUMINA, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 22
Average target price 156 $
Spread / Average Target -2,4%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Francis A. deSouza President, Chief Executive Officer & Director
Jay T. Flatley Executive Chairman
Sam A. Samad Chief Financial Officer & Senior Vice President
Mostafa Ronaghi Chief Technology Officer & Senior Vice President
Norman Fjeldheim Chief Information Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ILLUMINA, INC.25.75%23 408
THERMO FISHER SCIENTIF..12.49%62 801
DANAHER CORPORATION9.37%59 542
BOSTON SCIENTIFIC CORP..13.18%33 742
INTUITIVE SURGICAL, IN..15.95%28 581
PHILIPS-3.22%27 440
More Results